GL1X · GenesisL1 explorer

MolNFT v1 · #109263 · protein

Factor xia in complex with the inhibitor trans-N-{(1S)-1-[4-(3-amino- 2H-indazol-6-YL)PYRIDIN-2-yl]-2-phenylethyl}-4-(aminomethyl) cyclohexanecarboxamide

4WXI · Coagulation factor XI, light chain: “Factor xia in complex with the inhibitor trans-N-{(1S)-1-[4-(3-amino…”. X-ray diffraction, 2 ligands (3VM, SO4), 2 pockets (best druggability 0.43). MolNFT v1 #109263 on GenesisL1: 3D structure…

PDB
4WXI
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor XI, light chain
EC
3.4.21.27
UniProt
P03951
Ligands
3VM, SO4
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor XI, light chain (EC 3.4.21.27)protein23814% helix, 34% strandP03951

Ligands and binding sites

  • 3VM · trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)pyridin-2-yl]-2-phenylethyl}-4-(aminomethyl)cyclohexanecarboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11240.430.76183VM
21120.410.7617empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4WXI · FACTOR XIA IN COMPLEX WITH THE INHIBITOR trans-N-{(1S)-1-[4-(3-amino-2H-indazol-6-yl)pyrid… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.